Kuo-Chang Wen

https://orcid.org/0000-0001-6967-8037

Email19345@s.tmu.edu.tw

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

Experience

Director, Department of Obstetrics & Gynecology, Taipei Medical University Shuang Ho Hospital
Director, Division of Gynecology, Department of Obstetrics & Gynecology, Taipei Medical University Shuang Ho Hospital
Attending, Department of Obstetrics & Gynecology, Taipei Medical University Shuang Ho Hospital
Associate Professor, Department of Obstetrics & Gynecology, School of Medicine, College of Medicine, Taipei Medical University
Attending, Department of Obstetrics & Gynecology,Taipei Veterans General Hospital

Fingerprint

Dive into the research topics where Kuo-Chang Wen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

2 Active

人類子宮內膜癌淋巴結轉移的分子預測
Wen, K.
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
新聘教師研究補助
Wen, K.
6/1/20 → 5/1/21
Project: B - Project of TMU › g - Research Grants for Newly Hired Faculty

35 Citations
1 h-Index
2 Article

Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Wen, K. C., Sung, P. L., Wu, A. T. H., Chou, P. C., Lin, J. H., Huang, C. Y. F., Yeung, S. C. J. & Lee, M. H., Aug 21 2020, In: Journal of Ovarian Research. 13, 1, 95.
Research output: Contribution to journal › Article › peer-review

Open Access
PAX1/SOX1 DNA methylation and cervical neoplasia detection: A Taiwanese Gynecologic Oncology Group (TGOG) study
Lai, H. C., Ou, Y. C., Chen, T. C., Huang, H. J., Cheng, Y. M., Chen, C. H., Chu, T. Y., Hsu, S. T., Liu, C. B., Hung, Y. C., Wen, K-C., Yu, M. H. & Wang, K. L., Aug 2014, In: Cancer Medicine. 3, 4, p. 1062-1074 13 p.
Research output: Contribution to journal › Article › peer-review
35 Citations (Scopus)

Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Wen, K. (Contributor), Sung, P. (Contributor), Wu, T. A. (Contributor), Chou, P. (Contributor), Lin, J. (Contributor), Huang, C. F. (Contributor), Yeung, S. J. (Contributor) & Lee, M. (Contributor), Unknown Publisher, Jan 1 2020
DOI: 10.6084/m9.figshare.c.5099513.v1, https://springernature.figshare.com/collections/Neoadjuvant_metformin_added_to_conventional_chemotherapy_synergizes_anti-proliferative_effects_in_ovarian_cancer/5099513/1
Dataset
Additional file 2 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Wen, K. (Contributor), Sung, P. (Contributor), Wu, T. A. (Contributor), Chou, P. (Contributor), Lin, J. (Contributor), Huang, C. F. (Contributor), Yeung, S. J. (Contributor) & Lee, M. (Contributor), Unknown Publisher, Jan 1 2020
DOI: 10.6084/m9.figshare.12845525.v1, https://springernature.figshare.com/articles/figure/Additional_file_2_of_Neoadjuvant_metformin_added_to_conventional_chemotherapy_synergizes_anti-proliferative_effects_in_ovarian_cancer/12845525/1
Dataset
Additional file 4 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Wen, K. (Contributor), Sung, P. (Contributor), Wu, T. A. (Contributor), Chou, P. (Contributor), Lin, J. (Contributor), Huang, C. F. (Contributor), Yeung, S. J. (Contributor) & Lee, M. (Contributor), Unknown Publisher, Jan 1 2020
DOI: 10.6084/m9.figshare.12845531.v1, https://springernature.figshare.com/articles/figure/Additional_file_4_of_Neoadjuvant_metformin_added_to_conventional_chemotherapy_synergizes_anti-proliferative_effects_in_ovarian_cancer/12845531/1
Dataset
Additional file 3 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Wen, K. (Contributor), Sung, P. (Contributor), Wu, T. A. (Contributor), Chou, P. (Contributor), Lin, J. (Contributor), Huang, C. F. (Contributor), Yeung, S. J. (Contributor) & Lee, M. (Contributor), Unknown Publisher, Jan 1 2020
DOI: 10.6084/m9.figshare.12845528.v1, https://springernature.figshare.com/articles/figure/Additional_file_3_of_Neoadjuvant_metformin_added_to_conventional_chemotherapy_synergizes_anti-proliferative_effects_in_ovarian_cancer/12845528/1
Dataset
Additional file 1 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Wen, K. (Contributor), Sung, P. (Contributor), Wu, T. A. (Contributor), Chou, P. (Contributor), Lin, J. (Contributor), Huang, C. F. (Contributor), Yeung, S. J. (Contributor) & Lee, M. (Contributor), Unknown Publisher, Jan 1 2020
DOI: 10.6084/m9.figshare.12845522.v1, https://springernature.figshare.com/articles/figure/Additional_file_1_of_Neoadjuvant_metformin_added_to_conventional_chemotherapy_synergizes_anti-proliferative_effects_in_ovarian_cancer/12845522/1
Dataset